Naltrexone And Bupropion
A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects
Orexigen Therapeutics, Inc · Phase 3 · Completed · Enrollment 1742
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| NB16 | Obesity or overweight | n/r | 56 | n/r | n/r |
| NB32 | Obesity or overweight | n/r | 56 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 56 | n/r | n/r |